Study of hysteroscopic repeat curettage as the first-line treatment in low-risk postmolar gestational trophoblastic neoplasia compared with the MTX single drug chemotherapy
low-risk postmolar gestational trophoblastic neoplasia (GTN)
World Health Organization(WHO) risk score≤4
Age≤60 years; female, Chinese women
Initial treatment
Patients with unconfirmed diagnosis of GTN
Patients with placental-site trophoblastic tumor (PSTT) or epithelioid trophoblastic tumor (ETT)
WHO risk score ≥5分
The diameter of a single metastatic lesion in the lung was ≥2cm
Women's Hospital School Of Medicine Zhejiang University
Lead sponsor
Sun Yat-sen University
Collaborator
Huazhong University of Science and Technology
Collaborator
Qilu Hospital of Shandong University
Collaborator